Mechanism of miR-143-3p inhibiting proliferation, migration and invasion of osteosarcoma cells by targeting MAPK7

10.1007/s40744-016-0050-2

10.1111/ajco.12346

10.1016/j.ocl.2015.08.022

10.2217/imt-2016-0048

10.1186/s13045-016-0373-z

Kumar RR, Boro A, Fuchs B. Involvement and clinical aspects of microRNA in osteosarcoma. Int J Mol Sci. 2016;17:1–8.

10.1038/nrd.2016.246

Sun X, Dai G, Yu L, et al. miR-143-3p inhibits the proliferation, migration and invasion in OS by targeting FOSL2. Sci Rep. 2018;8:1–10.

10.5483/BMBRep.2017.50.11.179

10.1093/nar/gkw550

10.17219/acem/62915

10.1007/s13402-017-0341-9

10.7150/jca.15061

Lin W, Lin W, Wang L, et al. Analysis of miR-148b expression differences in stage-I and II parosteal osteosarcoma. Oncol Lett. 2018;16:998–1002.

10.3892/ol.2016.5388

Wang L, He J, Xu H, et al. MiR-143 targets CTGF and exerts tumour-suppressing functions in epithelial ovarian cancer. Am J Transl Res. 2016;8:2716–2726.

10.18632/oncotarget.18671

10.1002/jcb.26158

Li D, Hu J, Song H, et al. miR-143-3p targeting LIM domain kinase 1 suppresses the progression of triple-negative breast cancer cells. Am J Transl Res. 2017;9:2276–2285.

10.2174/0929867324666170203123427

10.5858/arpa.2015-0475-RS

10.18632/oncotarget.12908

10.1186/s12885-015-1455-y

10.1002/mc.22420